Observational studyProstate cancer and prostatic diseases2019

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer.

Nicholas G Nickols et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.